TIA
GILD icon

Traphagen Investment Advisors’s Gilead Sciences GILD Stock Holding History

Traphagen Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,140
Closed -$298K – 229
2026
Q1 		$298K Sell
2,140
-764
-26% -$107K 0.02% 153
2025
Q4 		$356K Buy
2,904
+28
+1% +$3.4K 0.03% 141
2025
Q3 		$319K Buy
2,876
+9
+0.3% +$1.02K 0.03% 148
2025
Q2 		$318K Sell
2,867
-11
-0.4% -$1.17K 0.03% 144
2025
Q1 		$323K Buy
2,878
+11
+0.4% +$1.14K 0.03% 134
2024
Q4 		$265K Sell
2,867
-1
-0% -$90 0.03% 145
2024
Q3 		$240K Sell
2,868
-168
-6% -$12.8K 0.02% 152
2024
Q2 		$208K Buy
3,036
+2
+0.1% +$133 0.02% 162
2024
Q1 		$222K Buy
3,034
+182
+6% +$14K 0.02% 161
2023
Q4 		$231K Buy
2,852
+1
+0% +$78 0.03% 157
2023
Q3 		$214K Hold
2,851
– – 0.03% 146
2023
Q2 		$220K Buy
2,851
+1
+0% +$80 0.03% 143
2023
Q1 		$236K Hold
2,850
– – 0.03% 137
2022
Q4 		$245K Sell
2,850
-390,496
-99% -$30.9M 0.04% 132
2022
Q3 		$17M Buy
393,346
+134,661
+52% +$8.49M 3.12% 9
2022
Q2 		$11.9M Buy
258,685
+151,713
+142% +$9.39M 2.17% 11
2022
Q1 		$5.33M Sell
106,972
-35,851
-25% -$2.29M 0.86% 20
2021
Q4 		$7.78M Sell
142,823
-20,261
-12% -$1.4M 1.28% 14
2021
Q3 		$8.91M Buy
163,084
+3,172
+2% +$223K 1.6% 13
2021
Q2 		$8.81M Buy
159,912
+13,217
+9% +$883K 1.5% 16
2021
Q1 		$7.83M Sell
146,695
-64,032
-30% -$4.13M 1.44% 16
2020
Q4 		$11.9M Buy
210,727
+17,171
+9% +$1.04M 2.14% 16
2020
Q3 		$10.7M Buy
193,556
+190,577
+6,397% +$13.2M 2.16% 15
2020
Q2 		$229K Buy
2,979
+1
+0% +$77 0.05% 113
2020
Q1 		$223K Buy
+2,978
New +$206K 0.06% 108
2019
Q3 		– Sell
-3,069
Closed -$207K – 116
2019
Q2 		$207K Buy
+3,069
New +$202K 0.06% 106

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Traphagen Investment Advisors's GILD Position: Q2 2026 in Review

Traphagen Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,140 shares — an estimated $298K sold.

Traphagen Investment Advisors first reported a position in GILD in Q2 2019 and held it in 26 quarters. The position peaked at $17M in Q3 2022. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Traphagen Investment Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Traphagen Investment Advisors sold 2,140 Gilead Sciences shares in Q2 2026, an estimated $298K.
  • Traphagen Investment Advisors first reported a position in Gilead Sciences in Q2 2019 and held it in 26 quarters.
  • Traphagen Investment Advisors's Gilead Sciences position peaked at $17M in Q3 2022.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.